Lanlan Shen

14.3k citations
131 papers · 10.6k indexed · 1 hit paper · h-index 55

Lanlan Shen

122 papers receiving 10.4k citations

Hit Papers

Decitabine improves patient outcomes in myelodysplastic s...1.1k20062026201220192505007501000

Peers

Lanlan Shen
Comparison fields: 5 of 157
  • Hematology 1.5k
  • Molecular Biology 7.7k
  • Cancer Research 1.7k
  • Pathology and Forensic Medicine 1.2k
  • Oncology 1.7k
Replace Bruce D. Gelb with:
Bruce D. Gelb United States
Sharon A. Savage United States
Duanqing Pei China
Pablo Menéndez Spain
Moin A. Saleem United Kingdom
Yue Lu United States
Klaus Okkenhaug United Kingdom
Marsha A. Moses United States
Xiao Yang China
Gert Matthijs Belgium
Lanlan Shen relative to Bruce D. Gelb United States Bruce D. Gelb's profile →
Citations per field
00.5×4.3×
Bruce D. Gelb · 1×
Citations per year

Countries citing papers authored by Lanlan Shen

Since Specialization
Citations

This map shows the geographic impact of Lanlan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Shen more than expected).

Fields of papers citing papers by Lanlan Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Shen. The network helps show where Lanlan Shen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lanlan Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lanlan Shen Line = papers co-authored together Lanlan Shen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20241
4 20244
5 20241
6 202212
7 202017
8 201811
9 201444
10 201088
11 2010123
12 200937
13 2008100
14 200756
15 200787
16 200747
17 2007220
18 2006211
19 200680
20 2002209

About Lanlan Shen

Lanlan Shen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology, having authored 131 papers that have together received 10.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (76 papers), Cancer-related gene regulation (30 papers), RNA modifications and cancer (28 papers), Genetic factors in colorectal cancer (14 papers), Phase-change materials and chalcogenides (10 papers), Chalcogenide Semiconductor Thin Films (10 papers), Genomics and Chromatin Dynamics (9 papers) and Acute Myeloid Leukemia Research (9 papers). The work is most often cited by research in Hematology (1.5k citations), Molecular Biology (7.7k citations) and Cancer Research (1.7k citations). Lanlan Shen has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Jean‐Pierre J. Issa, Yutaka Kondo, Saira Ahmed, Jaroslav Jelı́nek, Stanley R. Hamilton, Hagop M. Kantarjian, Yi Guo, Robert A. Waterland, Han Y. H. Chen and Marcos R. Estecio. Their work appears in journals such as Cancer Research, PLoS ONE, Blood, Proceedings of the National Academy of Sciences and PLoS Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026